The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 27, 2021
Filed:
Dec. 23, 2016
Applicants:
Sorbonne Universite, Paris, FR;
Centre National DE LA Recherche Scientifique, Paris, FR;
Inserm (Institut National DE LA Santé ET DE LA Recherche Médicale), Paris, FR;
Inventors:
Florian Sennlaub, Paris, FR;
Bertrand Callippe, Paris, FR;
Xavier Guillonneau, Boulogne Billancourt, FR;
José-Alain Sahel, Paris, FR;
Assignees:
SORBONNE UNIVERSITE, Paris, FR;
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), Paris, FR;
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/28 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2845 (2013.01); A61K 9/0014 (2013.01); A61K 9/0048 (2013.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); C07K 2317/76 (2013.01);
Abstract
Disclosed are agents inhibiting the interaction between CFH and CD11b/18, as well as the use of such agents, in particular for treating inflammatory disorders, such as age-related macular degeneration.